Mikel Gurrea‐Rubio

CD6 is a target for cancer immunotherapy

Jeffrey H. Ruth, Mikel Gurrea‐Rubio, Kalana S. Athukorala et al. · JCI Insight · 2021 · 50 citations · Full text

Tumor Biology, Tumor Immunology, Cancer Immunosurveillance +13

Tenascin-C: A Novel Candidate Marker for Cancer Stem Cells in Glioblastoma Identified by Tissue Microarrays

Song Nie, Mikel Gurrea‐Rubio, Jianhui Zhu et al. · Journal of Proteome Research · 2014 · 47 citations

Novel Candidate Marker, Pathology, High-grade Gliomas +16

Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis

David A. Fox, Steven K. Lundy, Michael L. Whitfield et al. · Arthritis Research & Therapy · 2021 · 33 citations · Full text

Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma

Sirapa Vichaikul, Mikel Gurrea‐Rubio, M. Asif Amin et al. · JCI Insight · 2022 · 19 citations · Full text

Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis

Pamela J. Palisoc, Leah Vaikutis, Mikel Gurrea‐Rubio et al. · Frontiers in Immunology · 2022 · 13 citations · Full text

Immunology, Pathology, Dermatology +24